HomeNeuropathy Management

Disease Modifying Agents

Peripheral neuropathy with established sensory loss is the predominant factor leading to foot ulcerations and non-traumatic amputations in diabetics. Disease modifying agents systemically manage both pain and sensory loss by addressing the underlying pathophysiology of the disease.


 
Metanx®
Pamlab, LLC
Metanx® is indicated for diabetic patients experiencing numbness, tingling and burning sensations in their feet. More
1